Table 1-A
|
Table 1-B
|
---|
Tissu samples (n = 46)
|
Saliva samples: Control population (n = 18)
|
---|
|
Median
|
Min
|
Max
| |
Median
|
Min
|
Max
|
---|
Age
|
56.7
|
41.2
|
77.7
|
Age
|
53
|
32
|
71
|
| |
Qt
|
%
| | |
Qt
|
%
|
Sex
|
Woman
|
4
|
8.7
|
Sex
|
Woman
|
6
|
33.3
|
|
Men
|
42
|
91.3
| |
Men
|
12
|
66.6
|
Site
|
Larynx
|
8
|
17.4
| | | | |
|
Oral cavity
|
8
|
17.4
|
Saliva samples: HNSCC population (n = 51)
|
|
Hypopharynx
|
7
|
15.2
| |
Median
|
Min
|
Max
|
|
Oropharynx
|
23
|
50
|
Age
|
59
|
41
|
83
|
T Stage
|
1
|
1
|
2.2
| | |
Qt
|
%
|
|
2
|
11
|
23.9
|
Sex
|
Woman
|
6
|
11.8
|
|
3
|
19
|
41.3
| |
Men
|
45
|
88.2
|
|
4
|
15
|
32,6
| | | | |
N Stage
|
0
|
18
|
39.1
|
Site
|
Larynx
|
5
|
9.8
|
|
1
|
4
|
8.7
| |
Oral cavity
|
11
|
21.7
|
|
2
|
23
|
50
| |
Hypopharynx
|
8
|
15.7
|
|
3
|
1
|
2.2
| |
Oropharynx
|
27
|
52.8
|
M Stage
|
0
|
46
|
100
|
T Stage
|
1
|
6
|
11.8
|
|
1
|
0
|
0
| |
2
|
12
|
23.5
|
| | | | |
3
|
14
|
27.4
|
Grade
|
1
|
13
|
28.3
| |
4
|
19
|
37.3
|
|
2
|
27
|
58.7
| | | | |
|
3
|
6
|
13
|
N Stage
|
0
|
17
|
33.2
|
| | | | |
+
|
34
|
66.7
|
Death
|
Yes
|
21
|
45.7
| | | | |
|
No
|
25
|
54.3
|
M Stage
|
0
|
50
|
1.9
|
| | | | |
1
|
1
|
98.1
|
Follow-up
|
Controlled
|
25
|
54.3
| | | | |
|
Progression
|
10
|
21.7
| | | | |
|
Recurrence
|
11
|
23.9
| | | | |
- Qt: quantity
- %: percentage